Apyx Medical Corporation Stock
Equities
APYX
US03837C1062
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.325 USD | -3.99% | -9.25% | -49.43% |
Apr. 05 | Archon Capital Management Engages with Apyx Medical Corporation | CI |
Apr. 01 | Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation | CI |
Financials (USD)
Sales 2024 * | 49.94M | Sales 2025 * | 54.52M | Capitalization | 47.81M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -25M | EV / Sales 2024 * | 0.96 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.88 x |
P/E ratio 2024 * |
-1.77
x | P/E ratio 2025 * |
-1.98
x | Employees | 252 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corporation
1 day | +4.55% | ||
1 week | -10.97% | ||
Current month | +1.47% | ||
1 month | -22.03% | ||
3 months | -30.65% | ||
6 months | -38.94% | ||
Current year | -47.33% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 17-12-14 |
Andrew Makrides
FOU | Founder | 82 | 77-12-31 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | Dec. 03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 77-12-31 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 11-03-14 |
Craig Swandal
BRD | Director/Board Member | 63 | 18-03-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.325 | -3.99% | 7 082 |
24-04-18 | 1.38 | +4.55% | 66,774 |
24-04-17 | 1.32 | -5.04% | 89,880 |
24-04-16 | 1.39 | +0.72% | 26,856 |
24-04-15 | 1.38 | -5.48% | 82,830 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.33% | 47.81M | |
-4.36% | 183B | |
-3.87% | 105B | |
-4.38% | 67.36B | |
+8.23% | 51.77B | |
+15.54% | 47.29B | |
-1.73% | 40.2B | |
+7.16% | 27.62B | |
-16.12% | 21.75B | |
-1.68% | 25.51B |
- Stock Market
- Equities
- APYX Stock